Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications
Alberto Enrico Maraolo, Maria Mazzitelli, Enrico Maria Trecarichi, Antonio Riccardo Buonomo, Carlo Torti, Ivan Gentile
Topics & Concepts
MedicinePseudomonas aeruginosaTazobactamInternal medicinePneumoniaAdverse effectIntensive care medicinePopulationAntibioticsAntibiotic resistanceMicrobiologyEnvironmental healthBacteriaGeneticsImipenemBiologyAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyPneumonia and Respiratory Infections